0000905718-15-000688.txt : 20150814
0000905718-15-000688.hdr.sgml : 20150814
20150814080114
ACCESSION NUMBER: 0000905718-15-000688
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150813
FILED AS OF DATE: 20150814
DATE AS OF CHANGE: 20150814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marucci Anthony S
CENTRAL INDEX KEY: 0001429933
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 151052590
MAIL ADDRESS:
STREET 1: 66 COLD HILL DRIVE
CITY: MENDAHM
STATE: NJ
ZIP: 07945
4
1
marucci_form4aug132015.xml
OWNERSHIP DOCUMENT
X0306
4
2015-08-13
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001429933
Marucci Anthony S
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD
HAMPTON
NJ
08827
1
1
0
0
President and CEO
Common Stock, par value $0.001 per share
2015-08-13
4
P
0
5800
16.8099
A
50028
D
Includes 340 shares of common stock acquired under the Company's 2004 Employee Stock Purchase Plan on June 30, 2015.
/s/ Avery W. Catlin, attorney in fact for Anthony S. Marucci
2015-08-13